PeptideUnicorn
Metabolic Moderate Evidence

Tesamorelin

Tesamorelin

1 min read
Amino Acids
44
Molecular Weight
5135.9 Da
Routes
subcutaneous
Primary Uses
Visceral fat research, Metabolic signaling

Regulatory Status

🇺🇸 United States
Prescription Only

A peptide with an established pharmaceutical history that still intersects with broader compounding policy debates.

FDA · Updated Apr 2026

🇬🇧 United Kingdom
Restricted

Availability depends on licensed access pathways.

MHRA · Updated Apr 2026

🇦🇺 Australia
Restricted

Prescription-only context where available.

TGA · Updated Apr 2026

🏅 WADA
Banned

Growth-hormone signaling class remains restricted in sport.

WADA · Updated Apr 2026

Overview

Tesamorelin stands out because it has a clearer clinical lineage than many research peptides. That makes it a useful reference point when discussing how the FDA may differentiate between better-characterized compounds and the broader gray-market peptide ecosystem.

Continue Reading

Readers also explore

All peptides →
Growth Hormone

Sermorelin

Sermorelin Acetate

Growth hormone signaling · Body composition research

Open profile
Growth Hormone

CJC-1295

CJC-1295 with Drug Affinity Complex

growth hormone optimisation · body composition · sleep quality

Open profile
Growth Hormone

Ipamorelin

Ipamorelin Acetate

growth hormone release · muscle growth · fat loss

Open profile

Authored and reviewed by PeptideUnicorn editorial board. Last reviewed .

Education only, not medical advice. Medical disclaimer